Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
A.M. Best Co.
A.M. Best Upgrades Ratings of Blue Whale Re Ltd.
April 24th, 2009
A.M. Best Co. has upgraded the financial strength rating to A (Excellent) from A- (Excellent) and issuer credit rating to “a” from “a-” of Blue Whale Re Ltd. (Blue Whale Re) (headquartered in New York, NY). The outlook for both ratings is stable. The ratings reflect Blue Whale Re’s strong capitalization and its conservative operating strategy. The ratings also consider its critical and central role and favorable profile as part of Pfizer Inc. (Pfizer) (NYSE: PFE), as well as the company’s excellent operating performance. Partially offsetting these positive rating factors are the company’s very large gross and net underwriting exposures to property losses and its...
Source: Health Business Week (2009-04-24)
|
